1)donor specific blood transfusion供体特异性输血
1.Methods Animals were divided into four groups: group I, isografts; groupⅡ, allografts; and group Ⅲ, allografts treated with donor specific blood transfusion(DST) after liver transplantation.目的 探讨供体特异性输血 (DST)预处理后大鼠同种肝移植物一氧化氮合酶 (NOS)的动力学变化。
2.The end-to-side anastomosis of donor abdominal aorta patch with arteria mesenterica superior pedicle and recipient abdominal aorta was performed according to the microsurgical technique,donor specific blood transfusion during the operation,an end-to-end anastomosis between the donor portal vein and the left renal vein of recipient using the cuff technique.方法供、受体手术均双人操作,整体切取供体节段小肠,术中原位冷灌注,4℃UW液保存;受体采用显微外科技术行带供体小肠的腹主动脉补片与受体腹主动脉端侧吻合,术中经受体左肾静脉行供体特异性输血,利用Cuff套管技术将供体的门静脉与受体的左肾静脉端端吻合。
2)donor-specific blood transfusion供体特异性输血
1.ObjectiveTo observe the impact of donor-specific blood transfusion on the recovery during perioperative period in living related kidney transplantation.目的探讨供体特异性输血对亲体肾移植患者围手术期并发症和术后人肾存活率的影响。
3)Donor-specific transfusion供体特异输注
4)Donor specific transfusion供者特异性输注
英文短句/例句
1.Research progress of immune tolerance induced by donor specific transfusion in renal transplantation供者特异性输注诱导肾移植受者免疫耐受的研究进展
2.Donor Specific Transfusion Combined with Dexamethasone Treatment Induced Long-term Survival of Skin Grafts in Mice;供者特异性输注联合地塞米松延长小鼠皮肤移植物存活的研究
3.Detection of donor-derived chimeric cells in peripheral lymphocytes of renal allograft recipients and the pilot study between donor specific bone marrow transfusion and chimerism;肾移植受者外周血淋巴细胞嵌合体检测及供者特异性骨髓输注对嵌合体影响的初步观察
4.Change of Activity of NF-κB p65 in Mice with Peripheral Tolerance Induced by DST;供者特异性脾细胞输注诱导外周耐受小鼠不同组织细胞内NF-κB p65的活性变化
5.The Impact of Chimerism in Perpheral Mononuclear Cells of Renal Allograft Recipients and Clinical Significance with Donor Bone Marrow Cells Infusion;供体骨髓特异性输注对肾移植受者外周血嵌合体的影响及临床意义
6.Infusion Donor Bone Marrow Cells to Induce Donor Specific Hypo-reactivity and Study Its Mechanism;供体骨髓输注诱导器官移植后特异性免疫低反应及机制
7.Detect and characterize platelet-reactive antibodies in patients who were refractory to platelet transfusions血小板输注无效患者体内血小板反应性抗体特异性调查研究
8.Five patients with malignant hematonosis were received donor lymphocyte infusion(DLI) after transplantation.对5例恶性血液病实施供者淋巴细胞输注。
9.Effect of Heterogenous DLI on Mouse Treated with Allo-BMT Post Nonlethal Preconditioning不同成分供者淋巴细胞输注对非清髓小鼠异基因骨髓移植的影响
10.Correlation between anti-donor-specific antibodies and acute rejection after renal transplantation抗供者特异性抗体与肾移植后的急性排斥反应
11.Study on the Mechanism of Donor Specific Immune Tolerance That Induced by the Alloreactive NK Cells;异体反应性NK细胞诱导供者特异性耐受的作用机理初探
12.The Platelet GP Specific Antibodies and HLA Antibodies in PTR Patients血小板特异性抗体及HLA抗体引起血小板输注无效的研究
13.Effects of Donor Spleen Leukomonocytes Transfusion and FK506 on Cardiac Allo-transplantation in Mice during Acute Rejection;供体脾淋巴细胞输注及FK506对同种异体小鼠心脏移植急性排斥反应的影响
14.Quantitation, Phenotypic and Functional Analyses of HCMV Specific Cytotoxic T Lymphocytes in Peripheral Blood Monocyte Lymphocytes from Healthy Chinese HLA-A2~+ Donors;健康HLA-A2~+供者HCMV特异性CTL的频率及其表型和功能分析
15.Establishment of HPA-typed Platelet Donor Registry and Analysis of Effect of Platelet TransfusionHPA基因型供者库的建立及血小板输注效果分析
16.The latest advances of research on donor lymphocyte infusion in treatment of leukemia供者淋巴细胞输注研究在白血病治疗中的进展
17.ObjectiveTo evaluate the efficacy and complications of donor lymphocyte infusion (DLI) following nonmyeloablative stem cell transplantation(NSCT)for the patients with hematologic diseases.【目的】研究非清髓性造血干细胞移植治疗血液病和供者淋巴细胞输注的疗效及并发症。
18.Half-effective Target Plasma Concentration of Propofol for Respiratory Depression in Different Gender and Different Age Patients;不同年龄及性别患者靶控输注异丙酚抑制呼吸的半数有效血浆浓度
相关短句/例句
donor-specific blood transfusion供体特异性输血
1.ObjectiveTo observe the impact of donor-specific blood transfusion on the recovery during perioperative period in living related kidney transplantation.目的探讨供体特异性输血对亲体肾移植患者围手术期并发症和术后人肾存活率的影响。
3)Donor-specific transfusion供体特异输注
4)Donor specific transfusion供者特异性输注
5)donor specific antibody供者特异性抗体
6)Donor-specific供体抗原特异性
延伸阅读
周期性特异性药物周期性特异性药物 仅能杀灭*细胞增殖周期中某一期癌细胞的抗癌药物。依其作用又分为两类:①作用于S期药物,如*羟基脲、*阿糖胞苷,甲氨蝶呤、巯基嘌呤、硫鸟嘌呤等。其中前两种药物特异性较高,主要干扰DNA合成,但因也能干扰 RNA的合成,可能起到一定的自限作用。临床上宜缓慢静滴或肌注给药。②作用于M期的药物,如长春新碱等。